Increasing both the number of shares and share price, iTeos Therapeutics has raised more than $201m in an offering that provided an exit to 6 Dimensions Capital.

US-based immuno-oncology drug developer iTeos Therapeutics raised more than $201m in a listing on Friday that offered an exit to 6 Dimensions Capital, the investment firm co-founded by pharmaceutical company WuXi AppTec. The company priced its shares at $19, above its previous target of $18, and upped the number of shares by approximately 350,000 to…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.